Other studies have also found that PFN2 has different expression patterns and effects in NSCLC, small cell lung cancer, and gastric cancer (Hippo et al., 2002; Yan et al., 2017; Cao et al., 2020). Here, PFN2 is linked to small cell lung carcinoma.